- Report
- March 2024
- 180 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- December 2023
- 92 Pages
Global
From €4756EUR$4,950USD£4,083GBP
- Drug Pipelines
- September 2023
- 900 Pages
Global
From €2883EUR$3,000USD£2,474GBP
- Report
- February 2024
- 265 Pages
Global
From €5285EUR$5,500USD£4,537GBP
- Report
- March 2024
- 188 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- March 2024
- 187 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- March 2024
- 199 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- June 2023
- 150 Pages
Global
From €4756EUR$4,950USD£4,083GBP
- Report
- June 2023
- 120 Pages
Global
From €5717EUR$5,950USD£4,908GBP
- Report
- December 2023
- 200 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- May 2024
- 492 Pages
Global
From €4756EUR$4,950USD£4,083GBP
- Report
- May 2024
- 272 Pages
Global
From €5381EUR$5,600USD£4,619GBP
- Report
- March 2024
- 145 Pages
Global
From €3746EUR$3,899USD£3,216GBP
- Report
- November 2023
- 143 Pages
Global
From €2401EUR$2,499USD£2,061GBP
- Report
- March 2024
- 138 Pages
Global
From €3746EUR$3,899USD£3,216GBP
- Report
- November 2023
- 138 Pages
Global
From €2401EUR$2,499USD£2,061GBP
- Report
- February 2024
- 120 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- January 2024
- 185 Pages
Global
From €4708EUR$4,900USD£4,042GBP
- Report
- October 2023
- 189 Pages
Global
From €4708EUR$4,900USD£4,042GBP
Targeted Drug Delivery System (TDDS) is a specialized area within the broader pharmacological field of Drug Delivery. TDDS aims to direct medication to specific cells, tissues, or organs, thereby increasing the concentration of the drug at the intended site of action while minimizing its presence in the rest of the body. This method potentially reduces side effects and enhances treatment efficacy. The market for these systems encompasses a wide range of technologies and platforms, such as nanoparticles, liposomes, and biodegradable polymers designed to release pharmaceutical compounds in a controlled manner. The field has been propelled by advances in biotechnology, nanotechnology, and molecular biology, which have contributed to the development of novel targeted drug delivery mechanisms. These include antibodies, receptor-mediated delivery systems, and gene-delivery vectors. TDDS is used in addressing various medical conditions, with cancer therapy being a particularly active area due to the need for precise drug delivery to tumor cells.
Several companies specialize in the research and development of Targeted Drug Delivery Systems, contributing to the maturation of this market. Some notable players in the field include Alkermes, BIND Therapeutics, DEPArray Technology, Genentech, Immunomedics, Inc., and Kite Pharma. These companies have a diverse product portfolio of targeted delivery technologies and are engaged in the development of innovative treatments for a wide range of diseases, striving to improve therapeutic outcomes and patient quality of life. Show Less Read more